New hope for Tough-to-Treat blood cancer: experimental drug enters human testing
Disease control
Not yet recruiting
This is the first study in people testing a new drug called SHR-3836 for multiple myeloma, a type of blood cancer. It aims to find a safe dose and see how the body handles the drug in 99 adults whose cancer has come back or stopped responding to standard treatments. The main goal…
Phase: PHASE1 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC